Czechia· CZ-0267517

TANATRIL

A imidapril product, registered in Czechia by VIATRIS HEALTHCARE LIMITED, Dublin. The same ATC class is registered in 6 of our 19 countries.

ATC C09AA16

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedTANATRILATCC09AA16REGISTER NO.CZ-0267517PACKS LISTED0CHECKEDJune 22, 2026

Where it is registered

Imidapril is registered in 6 of 19 countries.

Countries holding a registration under ATC C09AA16 (imidapril), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 4 of them publish a price we can compare per daily dose

Imidapril · ATC C09AA16

6 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Japan
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of imidapril costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Imidapril · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.24
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Manufacturer
VIATRIS HEALTHCARE LIMITED, Dublin
Country
Czechia (CZ)
ATC code
C09AA16
ATC class
Imidapril
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
June 22, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

21 interactions on record for imidapril.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Imidapril · interactions on record

21 records

21 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b2ecd619-7ce1-438c-a88c-7161ecbf03b4
GET /v1/drugs/b2ecd619-7ce1-438c-a88c-7161ecbf03b4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL NOB",
  "source": "sukl",
  "strength": "20MG",
  "pack_size": "20 II",
  "substance": "14186",
  "cz_kod_sukl": "0267517",
  "product_type": "CH",
  "registration_state": "R",
  "registration_number": "58/088/03-C"
}

See everything about imidapril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.